Idiopathic Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Idiopathic Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-09Clinical Trial Update: Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN [Phase 3]
A Phase 3 trial evaluating rituximab plus cyclosporine versus rituximab alone for idiopathic membranous nephropathy was terminated.
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy [Phase 2]
A Phase 2 trial evaluating intravenous belimumab versus placebo for idiopathic membranous nephropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-13Clinical Trial Update: Aliskiren in Patients With Idiopathic Membranous Nephropathy [NA]
A clinical trial evaluating aliskiren for idiopathic membranous nephropathy has been withdrawn.